Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 1427 Results Clear All
Trained on data spanning the human lifespan, a new tool developed at Gladstone can predict genes associated with aging and age-related diseases.
News Release Research (Publication) Cardiovascular Disease Theodoris Lab Aging
Gladstone Institutes is adding state-of-the-art laboratories in a newly constructed Mission Bay building.
History Institutional News News Release Genomic Immunology Data Science and Biotechnology Marson Lab Pollard Lab AI CRISPR/Gene Editing Genomics
San Francisco Chronicle—In one of the city’s biggest leases of 2026 so far, Gladstone Institutes has secured 105,000 square feet in the last major new building of San Francisco’s Mission Bay, as part of its expansion plans that include hiring 300 new scientists. (Subscription required.)
Institutional News
Cancer Research Institute—Colorectal cancer is the second leading cause of cancer-related death in the U.S. But despite decades of progress, immunotherapy still falls short for the vast majority of patients with this cancer. Gladstone Investigator Karin Pelka is working to change that by listening in on the molecular conversations happening inside the tumor itself.
Gladstone Experts Cancer Genomic Immunology Pelka Lab
Scientists at Gladstone are combining AI models with cutting-edge lab tools to finally make sense of the human genome.
AI Srivastava Lab Pollard Lab Engelhardt Lab Theodoris Lab Shipman Lab Ramani Lab Finkbeiner Lab Cardiovascular Disease Neurological Disease
In this video, Katie Pollard and Deepak Srivastava explain how Gladstone scientists are combining AI models with novel tools in the lab to finally decode the entire human genome.
Gladstone Experts Pollard Lab Srivastava Lab AI
In this video, Nadia Roan and Ashley George explain how they uncovered a new path toward long-term health without the need for daily HIV pills.
Gladstone Experts Research (Publication) HIV/AIDS Infectious Disease Roan Lab
New research offers a path toward life without daily HIV pills, suggesting common diabetes pill could help achieve long-term remission.
News Release Research (Publication) HIV/AIDS Infectious Disease Roan Lab
Nature—Gladstone Investigator Katerina Akassoglou weighs in on a new study showing that long-lasting damage to the blood–brain barrier after repeated head trauma may drive chronic inflammation and cognitive decline.
Gladstone Experts Akassoglou Lab
Science—Gladstone Investigator Ken Nakamura comments on a new study testing a method to deliver healthy mitochondria into cells. (Subscription required.)
Gladstone Experts Nakamura Lab
UCSF News—Gladstone Affiliate Investigator Justin Eyquem and his collaborators at Gladstone and UCSF demonstrated a new method to engineer CAR T cells directly inside the body, opening the door to a future off-the-shelf cancer treatment without chemotherapy.
Gladstone Experts Cancer Genomic Immunology Eyquem Lab
From Wisconsin to Gladstone, Kim Dam is helping engineer a next-generation vaccine platform designed to tackle some of the world’s most challenging infectious diseases.
Profile Infectious Disease
The San Francisco Standard—Deepak Srivastava offers perspective on the emerging use of mesenchymal stem-cells and the questions that remain about their therapeutic value.
Gladstone Experts Srivastava Lab
Authority Magazine—Gladstone President Deepak Srivastava is recognized as one of 15 innovators helping shape the future of medical technology.
Gladstone Experts Srivastava Lab
The Microbiologist—Gladstone Investigator Nadia Roan and her team have developed a novel tool, named HIV-seq, for profiling the features of rare HIV-infected cells from people with HIV.
Gladstone Experts HIV/AIDS Infectious Disease Roan Lab
